C.E. Credit for North American Center for Continuing Medical Education, LLC (NACCME): 1.50
Specialization: APA, CME, CNE, Pharmacology, Participation
In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity is intended for psychiatrists, primary care physicians, psychologists, physician assistants, psychiatric nurses, and other healthcare professionals who seek to improve the care of patients with mental health disorders.
After completing this activity, participants should be able to:
- Evaluate new and emerging antipsychotic agents for the management of schizophrenia in terms of efficacy, safety, and adherence
- Identify factors that contribute to nonadherence to medication regimens and the downstream consequences of suboptimal schizophrenia care
- Describe potential mechanisms for antipsychotic-associated weight gain and metabolic disorders and develop strategies to mitigate iatrogenic effects
To be eligible for documentation of credit, participants must participate in the full activity, and complete the evaluation form. Participants who successfully complete the evaluation form online may immediately print their documentation of credit.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
Expiration Date: 10/15/2021
For questions regarding this educational activity, please call 609-371-1137.